Animal welfare is a complex, multi-faceted issue with scientific, ethical,
 economic, cultural, social, religious and political dimensions. It is of growing interest to civil society and is one
of the priorities of the World Organization for Animal Health (OIE).

Animal welfare has always been at the heart of our business. All of our teams across Africa, the Middle East and Europe are fully committed to it.

With over 24 years of expertise, we have built trustful relationships with our private and institutional customers (veterinarians, breeders and pet owners) who rely on our innovative products and services to meet their needs.

Our vocation is to develop and supply a range of vaccines and medicines adapted to the requirements of the markets across which we operate.

Lobs International Health operates in over 30 countries in Africa, the Middle East and Eastern Europe, and over the past 10 years has experienced one of the strongest growth rates in Africa.

Our range of 90 medicines and healthcare products covers the 4 major therapeutic classes: vaccines, anti-infectives, anti-parasitics and vitamins, and meets the highest quality and control standards on the market.

Our GMP/GMP production site and R&D team enable us to constantly innovate and to introduce between 1 to 3 new products onto the market every year.


  • 90 animal health medicines and referenced products.
  • Marketing authorizations obtained in many countries (Europe, Maghreb, Africa), including 36 in the UEMOA (3rd laboratory in terms of the number of marketing authorizations in the UEMOA).
  • Some of the best-known products in Western Africa
  • LOBAZEN / LOBIDIUM, the leading product in 4 countries
  • More than 50 animal health professionals on the ground
  • Over 100 million ruminants treated each year
  • 0.05% quality defects in 2021


Europe de l'Ouest
Europe de l'Est
Moyen Orient